Cansortium's Revenue is Rising, Along With Forecast

Cansortium's rise in revenue is coming from Florida as the company forecasts 42% growth in 2022.

Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) announced financial results for the second quarter ended June 30, 2022. Cansortium said revenue increased 36% to $22.4 million versus last year’s $16.5 million for the same time period. This beat the Yahoo Finance average analyst estimate for revenue of $18 million. The company noted that its Florida revenue increased 33% to $18.8 million compared to $14.2 million. The net losses were trimmed to $11.9 million from last year’s $25 million for the same time period.

“We generated a record quarter of results in Q2, highlighted by double-digit revenue growth, margin expansion and a material increase in adjusted EBITDA and cash flow generation,” said CEO Robert Beasley. “The investments we have made to add scale and improve cultivation in Florida are paying dividends. Our Sweetwater indoor cultivation facility is now fully operational and the yields in our Tampa facility have doubled from the start of 2022, all of which has led to dramatically improved productivity at the store level and a consistent increase in new patient count. In fact, revenue in Florida was up 16% from Q1 without adding a single new store during the quarter.”

On June 30, 2022, the company had approximately $8.9 million of cash and cash equivalents and $69.3 million of total debt, with approximately 252.3 million fully diluted shares outstanding (based on treasury stock method and share price on July 31, 2022).

Beasley continued: “I am very proud of what our team has accomplished this year, however, we still have significant room to grow. We remain on track to open 4-5 new stores in Florida by year-end, and the final phase of our cultivation expansion in Tampa is nearly complete. We expect product from this new space to hit shelves in the next couple of months, just in time for one of our strongest periods of the year in Florida as we enter the holidays.”

Looking Ahead

Cansortium said it continues to expect revenue in 2022 to range between $90$95 million, reflecting an approximate 42% increase from 2021 at the midpoint. Cansortium also continues to expect adjusted EBITDA in 2022 to range between $25$28 million, reflecting an approximate 35% increase from 2021.

Debra Borchardt

Debra Borchardt is the Co-Founder, and Executive Editor of GMR. She has covered the cannabis industry for several years at Forbes, Seeking Alpha and TheStreet. Prior to becoming a financial journalist, Debra was a Vice President at Bear Stearns where she held a Series 7 and Registered Investment Advisor license. Debra has a Master's degree in Business Journalism from New York University.


Leave a Reply

Your email address will not be published. Required fields are marked *

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 2 days

MSO Halo Collective Closes Pistil Point Acquisition in Oregon

@GreenMarketRpt – 2 days

Michigan Researchers To Study Cannabis Treatments For Chronic Pain

@GreenMarketRpt – 2 days

Las Vegas Council Signs Off on Cannabis Consumption Lounges

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.